Member Info for Chan

Flying Now!

Good upward momentum over the recent few days. I think this will be a good long term bet with some good projects in the pipeline. Worth some DYOR

Hi dasv, glad this was of use looks like it may of helped the SP as you say. I didn't buy any, only because I'm locked in at present and no surplus cash, but will enter if the chance arises.

and lots of Buys since Market Opening http://www.investegate.co.uk/Article.aspx?id=200709030944241650D

dasv, this came through as Sunday's Star Tip from the Aim and Plus Newsletter via t1ps.com it appears they consider it a cheap stock. (You may have seen it) And so, in the current year to 31st March 2008, the group is likely to see a massive ramp up in revenues to £12.2 million, up from £3.89 million last year. Pre-tax profits of £1.58 million, equating to earnings of 2.2p should be comfortably achieved in the current period, climbing to earnings of 2.6p next year. With the shares trading at just 9.75p, the 4.4 times multiple falls to 3.75 times March 2009 earnings. The rating is far too low - buy.

substp you could try www.Babylon.com which is a free download I believe.

Hi GedW, I simply agree with your comment and Tom's too. I have followed and watched the SP drop since the 40P high in September 2005, always hoping there would be upturn. However stocks do get 'bruised' and investors move on. I do however consider this is a stock that could now improve and that was why I posted some of Tom's comment. Worth a longer term punt on a drop in the current SP.

Friday, 31st August 2007 13:44 Zi Medical says chief technical officer Gallagher cuts stake in co to 2.71 pct LONDON (Thomson Financial) - Zi Medical PLC said its chief technical officer George Gallagher sold 2.25 mln shares at 1.68 pence each, reducing his stake to 5.44 mln shares, or 2.71 pct in the company. The company said the sale was necessary so that Gallagher can part-fund the acquisition of the company's infusion business, Zimed Ltd. The company said Gallagher will resign from the board at its forthcoming EGM and approval for the disposal of Zimed will also be sought at the EGM. TFN.newsdesk@thomson.com

I have a few words on Jeff Hopmayer. Hopmayer you will remember promoted Blavod and then into share price strength sold his own shares. Not many but enough to kick the stock in the teeth. He made a strategic error in agreeing an equity line of credit proposal with Headstart. But I think his biggest failing was that he spent money on brand promotion in an imprudent fashion and with insufficient regard to the bottom line. Last time I spoke to him his comments were less than revealing. His departure is good news. Richard Ambler the original Blavod boss is less extrovert and as a t1ps reader I know he will read this. I hope that Ambler will grow Blavod steadily and profitably and achieve a trade sale in due course. This has been a dire tip and I am sorry for that. At 3.625p Blavod is valued at £2.65 million. Ongoing Blavod is achieving annual sales of £3.2 million and is profitable. I do not blame you all for not believing me but that really is too cheap. Average down and "buy." *TW owns this stock in his SIPP

Folks, the reality is that if the disposal plans get shareholder approval, the turnover of the company will be approximately halved, but its ongoing losses almost entirely eliminated. Whilst the remaining business of the company will be smaller, sales across all major brands are growing, which coupled with a significantly reduced and tightly monitored cost base will lead to a markedly improved bottom line. Crucially, the business will be left with no significant debt and the ability to achieve profitability within an acceptable timescale. i.e., the relative short term. It is already profitable at an operating level Today's news was accompanied by the resignation of the finance director, Tony Murphy - pretty irrelevant in light of these latest developments. Thus at 3.625p, the shares are a fraction of their highs, but also a fraction of what they could be once the sale gets the green light. Blavod has proven to be a thorough disappointment, however there is no point selling now as the refocusing on the profitable UK operations should bring at the very least, limited success for Blavod's reluctantly patient shareholders.

Hello GedW, just having a look back at this one. We did earn some dosh on this one, way back, and had a giggle. Well I sold some at that time and saved a few, but as you know they dived. Well with some new talent at the top, which they need, perhaps they could pull back up. We shall see!

Good Interims this morning see RNS_______ http://www.investegate.co.uk/Article.aspx?id=200708300701189774C and share news above.

The Recent Trades page appears stuck @ 10:42:58 109.5 but of course the stock is also traded on the Plus market and the last purchase I have is for 104.788. this is on 20min delay.

Sandhopper, k7pws spot on comments for the moment, Sand you timed it right to get 114.52p for a slice. Since the drop to circa 80p a few weeks ago, there's obviously alot of buying in anticipation of good results and yesterday's close of around 104p plus todays early rise would give many the opportunity of selling and making 20/25per cent in a few weeks. So with the shakey Market and the recent concern over the 'mentioned will' there is scepticism for the moment. It is clear that RCG Group are top in their field and run a slick operation. This time last year on this news the SP I suspect, would of reached 175p at least. However, despite the current market and sentiment this Company is an attractive investment and at a discount for sure. Look fowards to seeing the situation back to normal in due course, these Guys for sure know what they are doing and not to forget they are at three International Events during September which I'm sure will bring in extra orders. Good luck to All.

http://www.investegate.co.uk/Article.aspx?id=200708300701129730C

Yes GedW, Good News as expected not much to add.

SEE: http://www.investegate.co.uk/Article.aspx?id=200708290701069007C

Good news, see above Sharenews Wednesday, 29th August 2007 SovGEM says NAV/shr rises 18.24 pct in H1 vs H2 last year

that dasv is absolutely right with his last comment, this is an important moment in time for RCG and todays news would be a bit extra but not the main reason for the rise!

Good you posted sotwa, I did see the news and had to rush out but assumed folks would check the site with the expected awaited news, which is very likely to be ace. This would help the SP at this stage I would assume! http://www.rcg.tv/press/business/280807.html